Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer's Disease and Identifying Promising Drug Targets

Z Fišar - Biomolecules, 2022 - mdpi.com
Damage or loss of brain cells and impaired neurochemistry, neurogenesis, and synaptic and
nonsynaptic plasticity of the brain lead to dementia in neurodegenerative diseases, such as …

[HTML][HTML] An updated review of randomized clinical trials testing the improvement of cognitive function of Ginkgo biloba extract in healthy people and Alzheimer's …

H Liu, M Ye, H Guo - Frontiers in Pharmacology, 2020 - frontiersin.org
Alzheimer's disease (AD) is a common neurodegenerative disease, mainly manifested by
cognitive dysfunction. It seriously reduces the quality of life, and there is no ideal treatment …

AlCl3 induced learning and memory deficit in zebrafish

K Kaur, RK Narang, S Singh - Neurotoxicology, 2022 - Elsevier
Aluminium is a metal known to cause neurotoxicity in the brain, by promoting
neurodegeneration and affecting memory and cognitive ability. AlCl 3 has been reported to …

Tetrahydrobioterin (BH4) pathway: from metabolism to neuropsychiatry

H Fanet, L Capuron, N Castanon… - Current …, 2021 - ingentaconnect.com
Tetrahydrobipterin (BH4) is a pivotal enzymatic cofactor required for the synthesis of
serotonin, dopamine and nitric oxide. BH4 is essential for numerous physiological …

Primary hypothyroidism and Alzheimer's Disease: a tale of two

FH AlAnazi, HM Al-Kuraishy, A Alexiou… - Cellular and Molecular …, 2023 - Springer
Hypothyroidism (HPT) HPT could be a risk factor for the development and progression of
Alzheimer's disease (AD). In addition, progressive neurodegeneration in AD may affect the …

[HTML][HTML] Microglia-Mediated Inflammation and Neural Stem Cell Differentiation in Alzheimer's Disease: Possible Therapeutic Role of KV1.3 Channel Blockade

M Revuelta, J Urrutia, A Villarroel… - Frontiers in Cellular …, 2022 - frontiersin.org
Increase of deposits of amyloid β peptides in the extracellular matrix is landmark during
Alzheimer's Disease (AD) due to the imbalance in the production vs. clearance. This …

MicroRNA‑4722‑5p and microRNA‑615‑3p serve as potential biomarkers for Alzheimer's disease

Y Liu, Y Xu, M Yu - Experimental and therapeutic …, 2022 - spandidos-publications.com
The aim of the present study was to investigate the expression levels of microRNA (miR)‑
4722‑5p and miR‑615‑3p in Alzheimer's disease (AD) and their diagnostic value. Blood …

[HTML][HTML] The Wistar Kyoto rat: a model of depression traits

EE Redei, ME Udell, LCS Woods… - Current …, 2023 - ncbi.nlm.nih.gov
There is an ongoing debate about the value of animal research in psychiatry with valid lines
of reasoning stating the limits of individual animal models compared to human psychiatric …

Serum miR-128 serves as a potential diagnostic biomarker for Alzheimer's disease

M Zhang, W Han, Y Xu, D Li, Q Xue - Neuropsychiatric Disease and …, 2021 - Taylor & Francis
Background Although numerous microRNAs (miRNAs) have been discovered to participate
in the progression of Alzheimer's disease (AD), they are still difficult to apply in clinical work …

MicroRNA-mediated regulation of Nrf2 signaling pathway: Implications in disease therapy and protection against oxidative stress

M Ashrafizadeh, Z Ahmadi, S Samarghandian… - Life Sciences, 2020 - Elsevier
MicroRNAs (miRs) are small non-coding pieces of RNA that are involved in a variety of
physiologic processes such as apoptosis, cell proliferation, cell differentiation, cell cycle and …